Back to top

Psychedelic: Definium soars on study results for LSD-based depression treatment

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a study meeting its primary endpo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AtaiBeckley Inc (ATAI)

Definium Therapeutics, Inc. (DFTX)

Cybin Inc. (HELP)

NRx Pharmaceuticals, Inc. (NRXP)